Parathyroid hormone is the body's chief calcium regulator, acting on kidneys, gut, and bone, but current lab tests can misread its true levels due to hormone fragment interference.
3 target organsPTH regulates calcium balance by simultaneously acting on kidneys, gut (via vitamin D), and bone — a coordinated peptide hormone system
What the researchers found
Parathyroid hormone (PTH) is the master regulator of calcium and phosphate balance in the body, acting through three main pathways: increasing calcium reabsorption in the kidneys while blocking phosphate reabsorption, stimulating vitamin D activation to boost calcium absorption from food, and increasing bone resorption to release calcium and phosphate into the blood.
Parathyroid diseases can arise from genetic mutations affecting gland formation, hormone synthesis or secretion, or gland destruction. Treatment options range from surgical removal of overactive parathyroid tissue to hormone replacement, vitamin D supplementation, phosphate binders, and receptor activators. The review also highlights that current lab tests for PTH can be inaccurate due to interference from hormone fragments, phosphorylation, and amino acid oxidation.
Why it matters
PTH is one of the most important peptide hormones in the body, and its dysregulation underlies a wide range of conditions from osteoporosis to kidney stones to chronic kidney disease–related bone disorders. Understanding PTH biology is essential for anyone studying peptide therapeutics for bone health, including teriparatide and abaloparatide. The diagnostic challenges highlighted in this review — where lab tests can over- or underestimate active PTH — have real clinical consequences for patients being diagnosed and treated for parathyroid disorders.
The numbers in context
3 major PTH pathways · kidney, gut, and bone target organs · multiple immunoassay interference sources
How the study worked
This is a comprehensive narrative review published as a chapter in Advances in Clinical Chemistry, summarizing the current understanding of PTH biology, parathyroid disease genetics, therapeutic options, and laboratory diagnostic methods.
Who was studied
Review article covering PTH biology, parathyroid diseases, and diagnostic methods
What this study cannot tell us
As a narrative review rather than a systematic review, the study selection may not be exhaustive. The abstract does not provide specific quantitative data on treatment outcomes or diagnostic test performance metrics. The review focuses broadly rather than deeply on any single aspect of PTH biology.
How to read the evidence
This is rated as a Review/Reference because it is a comprehensive narrative review chapter summarizing existing knowledge about PTH biology, disease, treatment, and diagnostics rather than presenting new experimental data.
When this study was published
Published in 2021, this review provides a current overview of PTH biology and diagnostics. The fundamental biology described is well-established, while the diagnostic considerations remain actively relevant.
The bigger picture
PTH sits at the center of bone and mineral metabolism, making it foundational to understanding osteoporosis treatments like teriparatide (which is PTH 1-34) and abaloparatide (a PTHrP analog). The diagnostic challenges described here also connect to broader issues in peptide hormone measurement — a growing concern as more peptide-based therapies enter clinical use and accurate monitoring becomes critical for safe treatment.
Questions still open
- How can PTH immunoassays be improved to eliminate interference from hormone fragments and modifications?
- Could targeted genetic testing replace or supplement PTH blood tests for diagnosing parathyroid disorders?
- How do newer PTH-based osteoporosis therapies affect the accuracy of PTH diagnostic tests in treated patients?
Common questions
What does parathyroid hormone actually do in the body?
Why can PTH blood tests give inaccurate results?
Read the original research
Parathyroid hormone.
Advances in clinical chemistry, 101, 41-93
Citation
Leung, Edward Ki Yun. (2021). Parathyroid hormone.. Advances in clinical chemistry, 101, 41-93. https://doi.org/10.1016/bs.acc.2020.06.005